SHINE shares update on LEU-based method for Mo-99 production

01/21/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies said the Los Alamos National Laboratory had succeeded in producing and separating molybdenum-99 from uranium sulfate solution. SHINE said the development shows the low-enriched uranium-based method can be used to produce the isotope on a commercial scale. The company is looking to meet at least 50% of the U.S. demand for the isotope by 2016.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA